Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d3804653e152">The role of platinum-based neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) patients is highly controversial and it is not endorsed by current guidelines. Our meta-analysis aimed to better elucidate its activity, efficacy and safety. </p>

Related collections

Author and article information

Journal

Title: Annals of Oncology

Publisher: Oxford University Press (OUP)

ISSN (Print): 0923-7534

ISSN (Electronic): 1569-8041

Publication date Created: June 04 2018

Publication date (Electronic): June 04 2018

Affiliations

[1 ]Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

[2 ]Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino IRCCS per l’Oncologia, Genova, Italy

[3 ]Unit of Clinical Epidemiology, Ospedale Policlinico San Martino IRCCS per l’Oncologia, Genova, Italy

[4 ]Health Direction, Ospedale Policlinico San Martino IRCCS per l’Oncologia, Genova, Italy

[5 ]Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino IRCCS per l’Oncologia, Genova, Italy

[6 ]Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy

[7 ]Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Article

DOI: 10.1093/annonc/mdy127

PubMed ID: 29873695

SO-VID: 80f27283-474b-4def-809d-2738c6cf5f2b

License:

https://academic.oup.com/journals/pages/about_us/legal/notices

History

Data availability:

Comments

Comment on this article

scite_

Cited by 162

See all cited by